scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1050288296 |
P356 | DOI | 10.1186/2191-219X-2-13 |
P932 | PMC publication ID | 3351026 |
P698 | PubMed publication ID | 22464278 |
P5875 | ResearchGate publication ID | 223992859 |
P50 | author | Jan Plutnar | Q53173465 |
Hans-Jürgen Wester | Q128303541 | ||
P2093 | author name string | Johannes Notni | |
P2860 | cites work | PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study. | Q53315070 |
Positron flight in human tissues and its influence on PET image spatial resolution | Q53640691 | ||
67Ga binding to human serum proteins and tumor components. | Q54185799 | ||
Comparison of iron-59, indium-111, and gallium-69 transferrin as a macromolecular tracer of vascular permeability and the transferrin receptor | Q69754473 | ||
Gallium uptake by transferrin and interaction with receptor 1 | Q80307410 | ||
TRAP, a powerful and versatile framework for gallium-68 radiopharmaceuticals | Q82836384 | ||
Mechanisms of therapeutic activity for gallium | Q28292030 | ||
Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapy | Q31142241 | ||
Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium. | Q34119384 | ||
Osteogenesis imperfecta: questions and answers | Q35012487 | ||
A comparison between bisphosphonates and other treatments for osteoporosis | Q37781067 | ||
Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. | Q37781070 | ||
The relationship between the chemistry and biological activity of the bisphosphonates. | Q37865849 | ||
Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging | Q39461465 | ||
A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography. | Q42167262 | ||
Thermodynamics of bisphosphonates binding to human bone: a two-site model | Q42571306 | ||
A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting | Q46817663 | ||
NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model | Q46824743 | ||
P433 | issue | 1 | |
P921 | main subject | gallium | Q861 |
P304 | page(s) | 13 | |
P577 | publication date | 2012-03-30 | |
P1433 | published in | EJNMMI Research | Q27723773 |
P1476 | title | Bone-seeking TRAP conjugates: surprising observations and their implications on the development of gallium-68-labeled bisphosphonates | |
P478 | volume | 2 |
Q43595161 | A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates. |
Q39332186 | A monoreactive bifunctional triazacyclononane phosphinate chelator with high selectivity for gallium-68. |
Q46725531 | A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform |
Q26849276 | Clinical applications of Gallium-68 |
Q39605627 | Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. |
Q48248853 | Dendritic poly-chelator frameworks for multimeric bioconjugation |
Q28538187 | Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers |
Q42630126 | Evaluation of Ga-DOTA-(D-Asp)n as bone imaging agents: D-aspartic acid peptides as carriers to bone. |
Q53066975 | Gallium(III) complexes of NOTA-bis (phosphonate) conjugates as PET radiotracers for bone imaging. |
Q64897716 | Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC. |
Q31126059 | Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue |
Q48149537 | MA-NOTMP: A Triazacyclononane Trimethylphosphinate Based Bifunctional Chelator for Gallium Radiolabelling of Biomolecules. |
Q87980263 | Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators |
Search more.